WO2011110651A1 - Process for the preparation of 5-substituted 1-alkyltetrazoles - Google Patents

Process for the preparation of 5-substituted 1-alkyltetrazoles Download PDF

Info

Publication number
WO2011110651A1
WO2011110651A1 PCT/EP2011/053660 EP2011053660W WO2011110651A1 WO 2011110651 A1 WO2011110651 A1 WO 2011110651A1 EP 2011053660 W EP2011053660 W EP 2011053660W WO 2011110651 A1 WO2011110651 A1 WO 2011110651A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
alkyl
chlorine
process according
iii
Prior art date
Application number
PCT/EP2011/053660
Other languages
French (fr)
Inventor
Stéphane CAILLON-MORISSEAU
Pierre-Yves Coqueron
Jens-Dietmar Heinrich
Norbert Lui
Original Assignee
Bayer Cropscience Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Cropscience Ag filed Critical Bayer Cropscience Ag
Priority to CN201180013193.9A priority Critical patent/CN102906075B/en
Priority to ES11709678.4T priority patent/ES2450124T3/en
Priority to BR112012022882A priority patent/BR112012022882A2/en
Priority to KR1020127024560A priority patent/KR20130016233A/en
Priority to EP11709678.4A priority patent/EP2545040B1/en
Priority to US13/582,026 priority patent/US8536211B2/en
Priority to MX2012010443A priority patent/MX2012010443A/en
Priority to JP2012556528A priority patent/JP5792205B2/en
Priority to DK11709678.4T priority patent/DK2545040T3/en
Publication of WO2011110651A1 publication Critical patent/WO2011110651A1/en
Priority to IL221184A priority patent/IL221184A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Definitions

  • the present invention relates to a process for the preparation of 5-substituted 1-alkyltetrazoles.
  • 5-substituted 1-alkyltetrazoles are important intermediate compounds in active ingredient manufacture (see e.g. WO 2010/000841).
  • 5-substituted 1-alkyltetrazoles can be prepared by lithiation of 1-methyltetrazole at -70°C (cf. Can. J. Chem. 1971, 49, 2139-2142).
  • the yield using the example of 5-benzoyl- 1-methyltetrazole is only 41%.
  • the 1-methyltetrazole used likewise has to be prepared in a multistage synthesis sequence. For an industrial reaction, the low temperatures and the expensive use of butyllithium are disadvantageous.
  • the invention therefore provides a process for the preparation of 5-substituted 1-alkyltetrazoles of the formula (I)
  • R is alkyl, or phenyl optionally monosubstituted by halogen, cyano, nitro, Ci-Cg-alkyl, Ci-Cg- alkoxy, methylsulphonyl, trifluoromethyl or aryl, R is Ci-Ci2-alkyl, Ci-Ci2-haloalkyl or an alkoxyalkyl of the formula -[A-0] m -B,
  • A is C2-C i-alkanediyl (alkylene)
  • B is Ci-Ce-alkyl
  • n 1 or 2 characterized in that
  • R 3 is sodium, potassium, tetrabutylammonium, trimethylsilyl, diphenylphosphoryl, optionally in the presence of a base.
  • the acid chlorides used as starting materials when carrying out the process according to the invention are generally defined by the formula (II).
  • R 1 is preferably Ci-Cg-alkyl, or phenyl optionally monosubstituted by fluorine, chlorine, bromine, iodine, cyano, nitro, Ci-C6-alkyl, methylsulphonyl, trifluoromethyl or phenyl or naphthyl.
  • R 1 is p articularly preferably Ci-Q-alkvl. or phenyl optionally monosubstituted by fluorine, chlorine,
  • R 1 is very particularly preferably methyl, ethyl, n-propyl, isopropyl, n-, i-, s- or t-butyl, or phenyl optionally monosubstituted by fluorine, chlorine, methyl, t-butyl, methoxy or ethoxy,
  • R 1 is e ⁇ ecially_preferably unsubstituted phenyl.
  • X is preferably fluorine, chlorine or bromine.
  • X is particularly preferably fluorine or chlorine.
  • X is very particularly preferably chlorine.
  • Acid chlorides of the formula (II) are known, e.g. commercially available, or can be prepared by known processes.
  • alkyl isocyanides further used as starting materials for carrying out the process according to the invention are generally defined by the formula (III).
  • R 2 is preferably Ci-Cg-alkyl, Ci-Cg-haloalkyl or an alkoxyalkyl of the formula -[A-0] m -B.
  • R " is particularly preferably Ci-C 4 -alkyl, Ci-C 4 -haloalkyl or an alkoxyalkyl of the formula -[A-0] m - B.
  • R is very particularly preferably methyl, ethyl, trifluoromethyl, or an alkoxyalkyl of the formula
  • R " is especially preferably methyl.
  • A is p referabl y -(CH 2 ) 2 -, -(CH 2 ) 3 -, -CH(CH 3 )- or -CH(CH 3 )CH 2 -.
  • A is particularly preferably -(CHoW or -CH(CH 3 )CH 2 -.
  • A is very particularly preferably -(CH 2 ) 2 -.
  • B is preferably Ci-C6-alkyl.
  • B is particularly preferably Ci-C i-alkyl.
  • B is very particularly preferably methyl or ethyl.
  • m is preferably 1.
  • Alkyl isocyanides of the formula (III) are known, e.g. commercially available, or can be prepared by known processes (cf. Angew. Chem. Int. Ed. 1965, 4, 472 -484).
  • R 3 is preferably sodium or trimethylsilyl.
  • R is particularly preferably sodium.
  • Azides of the formula (V) are known, e.g. commercially available, or can be prepared by known processes.
  • alkyl on its own or in combination with other terms, such as, for example, arylalkyl or alkoxy - refers to linear or branched saturated hydrocarbon chains having up to 12 carbon atoms, i.e. Ci- Ci2-alkyl, preferably with up to 6 carbon atoms, i.e. Ci-C6-alkyl, particularly preferably having up to 4 carbon atoms, i.e. Ci-C i-alkyl.
  • alkyls examples include methyl, ethyl, n-propyl or isopropyl, n-, i-, s- or t-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl and n-dodecyl.
  • the alkyls can be substituted with a suitable substituent, e.g. with halogen.
  • aryl on its own or in combination with other terms - refers to cyclic aromatic non-condensed or condensed groups which have 5 to 18 carbon atoms. Preferred aryls have 6 to 14 carbon atoms (e.g phenyl or naphthyl). Among the aryls, phenyl is particularly preferred.
  • Halogen or "Hal” stands for fluorine, chlorine, bromine or iodine.
  • the second reaction step (2) is optionally carried out in the presence of a base. However, this step can also be carried out without base, although the reaction rate is faster with base. It is described in the literature (cf. Chem. Ber. 1961, 94, 1116-1121) that the a-keto carboxylic acid imide chlorides cleave with strong bases such as alkali metal hydroxides, ammonia and also amines with elimination. Surprisingly, the addition of base in the process according to the invention is advantageous.
  • the reaction preferably takes place in the presence of a base. Suitable bases are organic and inorganic bases which are usually used in such reactions.
  • bases which are selected for example from the group of tertiary amines, such as trimethylamine, triethylamine, tributylamine, ⁇ , ⁇ -dimethylaniline, N,N- dimethylbenzylamine, pyridine, alkylpyridines, such as 2,6-dimethylpyridine, 2-methyl-5-ethylpyridine, N-methylpiperidine, N-methylpyrolidone, N,N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclononene (DBN) and diazabicycloundecene (DBU).
  • tertiary amines such as trimethylamine, triethylamine, tributylamine, ⁇ , ⁇ -dimethylaniline, N,N- dimethylbenzylamine, pyridine, alkylpyridines, such as 2,6-dimethylpyridine, 2-methyl-5-ethylpyridine, N-methylpipe
  • the imines of the formula (IV) obtained in step (1) can either be isolated or be further reacted directly in situ. Preferably, the imines of the formula (IV) are further reacted in situ.
  • step (1) it is preferred according to the invention to introduce the acid chloride of the formula (II) as initial charge either without solvent, i.e. without dilution, or in a suitable solvent, and then to add the alkylisocyanide of the formula (III), which is optionally dissolved in a suitable solvent. It is also possible to introduce the alkyl isocyanide as initial charge and to meter in the acid chloride. A parallel metered addition of the two components is also possible.
  • step (2) the reaction is preferably carried out in a solvent.
  • the solvents are preferably used in an amount such that the reaction mixture remains readily stirrable throughout the entire process.
  • Suitable solvents for carrying out the process according to the invention are all organic solvents inert under the reaction conditions. According to the invention, solvents are also understood as meaning mixtures of pure solvents.
  • Solvents suitable according to the invention are in particular ethers (e.g. ethyl propyl ether, methyl tert- butyl ether, w-butyl ether, anisole, phenetol, cyclohexyl methyl ether, dimethyl ether, diethyl ether, dimethyl glycol, diphenyl ether, dipropyl ether, diisopropyl ether, di-w-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetrahydrofuran, dioxane, and polyethers of ethylene oxide and/or propylene oxide); compounds such as tetrahydrothiophene dioxide and dimethyl sulphoxide, tetramethylene sulphoxide, dipropyl sulphoxid
  • amides e.g. hexamethylene phosphortriamide, formamide, N,N- dimethylacetamide, N-methylformamide, NN-dimethylformamide, NN-dipropylformamide, NN- dibutylformamide, N-methylpyrrolidine, N-methylcaprolactam, l,3-dimethyl-3,4,5,6-tetrahydro-2(lH)- pyrimidine, octylpyrrolidone, octylcaprolactam, l,3-dimethyl-2-imidazolinedione, N-formylpiperidine, NN'-l,4-diformylpiperazine); nitriles, such as acetonitrile, propionitrile, n- or isobutyronitrile or benz
  • the solvents used are preferably aromatic and/or aliphatic hydrocarbons, nitriles, ethers, in particular toluene, acetonitrile, THF, methylene chloride.
  • the process according to the invention can generally be carried out in vacuo, at atmospheric pressure or under superatmo spheric pressure.
  • the temperatures used can vary depending on the starting materials.
  • the process according to the invention in step (1) can be carried out at temperatures in the range from 20°C to 150°C, preferably at an internal temperature in the range from 30°C to 120°C, in particular in the range from 40°C to 110°C.
  • the process according to the invention in step (2) takes place at temperatures from -20 to +80°C, preferably at temperatures from -10 to +70°C.
  • the ratio of the acid halide of the formula (II) used to the alkyl isocyanide of the formula (III) used can vary.
  • the ratio of acid chloride of the formula (II) to the alkyl isocyanide of the formula (III) used is in the range from 1 : 1 to 1 :4, in particular in the range from 1 : 1 to 1 :2, specifically from 1 : 1.1 to 1 : 1.4.
  • the ratio of imine of the formula (IV) to the azide of the formula (V) can vary. A significant excess is not critical for the reaction, but is uneconomic.
  • the ratio of imine of the formula (IV) to the azide of the formula (V) is in the range from 1 : 1 to 1 :3, in particular in the range from 1 : 1 to 1 :2, specifically in the range from 1 : 1.0 to 1 : 1.3. Since preferably the imines of the formula (IV) are not isolated, the required quantitative ratio is determined with regard to the amount of acid halide of the formula (II) used.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a process for the preparation of 5-substituted 1-alkyltetrazoles.

Description

Process for the preparation of 5-substituted 1-alkyltetrazoles
The present invention relates to a process for the preparation of 5-substituted 1-alkyltetrazoles.
5-substituted 1-alkyltetrazoles are important intermediate compounds in active ingredient manufacture (see e.g. WO 2010/000841).
It is already known that 5-substituted 1-alkyltetrazoles can be prepared by lithiation of 1-methyltetrazole at -70°C (cf. Can. J. Chem. 1971, 49, 2139-2142). However, the yield using the example of 5-benzoyl- 1-methyltetrazole is only 41%. The 1-methyltetrazole used likewise has to be prepared in a multistage synthesis sequence. For an industrial reaction, the low temperatures and the expensive use of butyllithium are disadvantageous.
Another process for the preparation of 5 -benzoyl- 1-methyltetrazole is known from J Amer. Chem. Soc. 1963, 85, 2967-2976. Benzyl cyanide is reacted with ammonium azide to give 5-benzyltetrazole and then oxidized with chromium trioxide to give 5-benzoyltetrazole. The methylation to 5-benzoyl- 1-methyltetrazole takes place with diazomethane. This synthesis route is likewise disadvantageous as regards safety and economical aspects.
The preparation of l-cyclohexyl-5-acetyltetrazole by reacting acetyl chloride over cyclohexyl isocyanide with subsequent reaction with hydrazoic acid is also known (cf. Chem. Ber. 1961, 94, 1 1 16- 1 121). Hydrazoic acid is an unstable, extremely explosive and very toxic liquid which cannot be used on an industrial scale.
Starting from the known processes for the preparation of 5-substituted 1-alkyltetrazoles, the object now is how these can be prepared safely and cost-effectively, so that the process can also be used for the industrial production of 5-substituted 1-alkyltetrazoles. A process to give 5-substituted 1-alkyltetrazoles has now been found which overcomes the aforementioned disadvantages.
The invention therefore provides a process for the preparation of 5-substituted 1-alkyltetrazoles of the formula (I)
Figure imgf000002_0001
in which
R is alkyl, or phenyl optionally monosubstituted by halogen, cyano, nitro, Ci-Cg-alkyl, Ci-Cg- alkoxy, methylsulphonyl, trifluoromethyl or aryl, R is Ci-Ci2-alkyl, Ci-Ci2-haloalkyl or an alkoxyalkyl of the formula -[A-0]m-B,
A is C2-C i-alkanediyl (alkylene),
B is Ci-Ce-alkyl,
m is 1 or 2, characterized in that
(1) in a first step, an acid chloride of the formula (II)
O
R1Xx (ID in which R1 has the meanings given above and X is halogen,
is reacted with an alkyl isocyanide of the formula (III)
R— NC (III)
in which R2 has the meanings given above, and the imines of the formula (IV) obtained in this way
Figure imgf000003_0001
in which R1, R2 and X have the meanings given above, (2) are reacted in a second step with azides of the formula (V)
R— 3
in which
R3 is sodium, potassium, tetrabutylammonium, trimethylsilyl, diphenylphosphoryl, optionally in the presence of a base. The process according to the invention can be illustrated by reference to the following scheme:
Figure imgf000003_0002
The acid chlorides used as starting materials when carrying out the process according to the invention are generally defined by the formula (II).
R1 is preferably Ci-Cg-alkyl, or phenyl optionally monosubstituted by fluorine, chlorine, bromine, iodine, cyano, nitro, Ci-C6-alkyl, methylsulphonyl, trifluoromethyl or phenyl or naphthyl. R1 is particularly preferably Ci-Q-alkvl. or phenyl optionally monosubstituted by fluorine, chlorine,
Ci-C i-alkyl or Ci-C3-alkoxy,
R1 is very particularly preferably methyl, ethyl, n-propyl, isopropyl, n-, i-, s- or t-butyl, or phenyl optionally monosubstituted by fluorine, chlorine, methyl, t-butyl, methoxy or ethoxy,
R1 is e^ecially_preferably unsubstituted phenyl.
X is preferably fluorine, chlorine or bromine.
X is particularly preferably fluorine or chlorine.
X is very particularly preferably chlorine.
Acid chlorides of the formula (II) are known, e.g. commercially available, or can be prepared by known processes.
The alkyl isocyanides further used as starting materials for carrying out the process according to the invention are generally defined by the formula (III).
R2 is preferably Ci-Cg-alkyl, Ci-Cg-haloalkyl or an alkoxyalkyl of the formula -[A-0]m-B.
R" is particularly preferably Ci-C4-alkyl, Ci-C4-haloalkyl or an alkoxyalkyl of the formula -[A-0]m- B.
R is very particularly preferably methyl, ethyl, trifluoromethyl, or an alkoxyalkyl of the formula
-[A-0]m-B.
R" is especially preferably methyl.
A is preferably -(CH2)2-, -(CH2)3-, -CH(CH3)- or -CH(CH3)CH2-.
A is particularly preferably -(CHoW or -CH(CH3)CH2-.
A is very particularly preferably -(CH2)2-.
B is preferably Ci-C6-alkyl.
B is particularly preferably Ci-C i-alkyl.
B is very particularly preferably methyl or ethyl. m is preferably 1.
Alkyl isocyanides of the formula (III) are known, e.g. commercially available, or can be prepared by known processes (cf. Angew. Chem. Int. Ed. 1965, 4, 472 -484).
The azides further used as starting materials when carrying out the process according to the invention are generally defined by the formula (V). R3 is preferably sodium or trimethylsilyl.
R is particularly preferably sodium. Azides of the formula (V) are known, e.g. commercially available, or can be prepared by known processes.
The term "alkyl" - on its own or in combination with other terms, such as, for example, arylalkyl or alkoxy - refers to linear or branched saturated hydrocarbon chains having up to 12 carbon atoms, i.e. Ci- Ci2-alkyl, preferably with up to 6 carbon atoms, i.e. Ci-C6-alkyl, particularly preferably having up to 4 carbon atoms, i.e. Ci-C i-alkyl. Examples of such alkyls are methyl, ethyl, n-propyl or isopropyl, n-, i-, s- or t-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl and n-dodecyl. The alkyls can be substituted with a suitable substituent, e.g. with halogen.
The term "aryl" - on its own or in combination with other terms - refers to cyclic aromatic non-condensed or condensed groups which have 5 to 18 carbon atoms. Preferred aryls have 6 to 14 carbon atoms (e.g phenyl or naphthyl). Among the aryls, phenyl is particularly preferred.
"Halogen" or "Hal" stands for fluorine, chlorine, bromine or iodine.
The second reaction step (2) is optionally carried out in the presence of a base. However, this step can also be carried out without base, although the reaction rate is faster with base. It is described in the literature (cf. Chem. Ber. 1961, 94, 1116-1121) that the a-keto carboxylic acid imide chlorides cleave with strong bases such as alkali metal hydroxides, ammonia and also amines with elimination. Surprisingly, the addition of base in the process according to the invention is advantageous. The reaction preferably takes place in the presence of a base. Suitable bases are organic and inorganic bases which are usually used in such reactions. Preference is given to using bases which are selected for example from the group of tertiary amines, such as trimethylamine, triethylamine, tributylamine, Ν,Ν-dimethylaniline, N,N- dimethylbenzylamine, pyridine, alkylpyridines, such as 2,6-dimethylpyridine, 2-methyl-5-ethylpyridine, N-methylpiperidine, N-methylpyrolidone, N,N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclononene (DBN) and diazabicycloundecene (DBU).
The imines of the formula (IV) obtained in step (1) can either be isolated or be further reacted directly in situ. Preferably, the imines of the formula (IV) are further reacted in situ.
In step (1), it is preferred according to the invention to introduce the acid chloride of the formula (II) as initial charge either without solvent, i.e. without dilution, or in a suitable solvent, and then to add the alkylisocyanide of the formula (III), which is optionally dissolved in a suitable solvent. It is also possible to introduce the alkyl isocyanide as initial charge and to meter in the acid chloride. A parallel metered addition of the two components is also possible.
In step (2), the reaction is preferably carried out in a solvent. The solvents are preferably used in an amount such that the reaction mixture remains readily stirrable throughout the entire process. Suitable solvents for carrying out the process according to the invention are all organic solvents inert under the reaction conditions. According to the invention, solvents are also understood as meaning mixtures of pure solvents.
Solvents suitable according to the invention are in particular ethers (e.g. ethyl propyl ether, methyl tert- butyl ether, w-butyl ether, anisole, phenetol, cyclohexyl methyl ether, dimethyl ether, diethyl ether, dimethyl glycol, diphenyl ether, dipropyl ether, diisopropyl ether, di-w-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetrahydrofuran, dioxane, and polyethers of ethylene oxide and/or propylene oxide); compounds such as tetrahydrothiophene dioxide and dimethyl sulphoxide, tetramethylene sulphoxide, dipropyl sulphoxide, benzyl methyl sulphoxide, diisobutyl sulphoxide, dibutyl sulphoxide, diisoamyl sulphoxide; sulphones such as dimethyl, diethyl, dipropyl, dibutyl, diphenyl, dihexyl, methylethyl, ethylpropyl, ethylisobutyl and pentamethylene sulphone; aliphatic, cycloaliphatic or aromatic hydrocarbons (e.g. pentane, hexane, heptane, octane, nonane, such as the so-called "white spirits" with components having boiling points in the range for example from 40°C to 250°C, cymene, benzine fractions within a boiling interval from 70°C to 190°C, cyclohexane, methylcyclohexane, petroleum ether, ligroin, octane, benzene, toluene, xylene); halogenated hydrocarbons, such as chlorobenzene, dichlorobenzene, dichloromethane, chloroform, tetrachloromethane, dichloroethane or trichloroethane; esters (e.g. methyl, ethyl, butyl, isobutyl acetate, dimethyl, dibutyl or ethylene carbonate, propylene carbonate); amides (e.g. hexamethylene phosphortriamide, formamide, N,N- dimethylacetamide, N-methylformamide, NN-dimethylformamide, NN-dipropylformamide, NN- dibutylformamide, N-methylpyrrolidine, N-methylcaprolactam, l,3-dimethyl-3,4,5,6-tetrahydro-2(lH)- pyrimidine, octylpyrrolidone, octylcaprolactam, l,3-dimethyl-2-imidazolinedione, N-formylpiperidine, NN'-l,4-diformylpiperazine); nitriles, such as acetonitrile, propionitrile, n- or isobutyronitrile or benzonitrile; ketones such as acetone or mixtures thereof.
For the reaction according to the invention, the solvents used are preferably aromatic and/or aliphatic hydrocarbons, nitriles, ethers, in particular toluene, acetonitrile, THF, methylene chloride.
The process according to the invention can generally be carried out in vacuo, at atmospheric pressure or under superatmo spheric pressure.
The temperatures used can vary depending on the starting materials. The process according to the invention in step (1) can be carried out at temperatures in the range from 20°C to 150°C, preferably at an internal temperature in the range from 30°C to 120°C, in particular in the range from 40°C to 110°C. The process according to the invention in step (2) takes place at temperatures from -20 to +80°C, preferably at temperatures from -10 to +70°C.
The ratio of the acid halide of the formula (II) used to the alkyl isocyanide of the formula (III) used can vary. Preferably, the ratio of acid chloride of the formula (II) to the alkyl isocyanide of the formula (III) used is in the range from 1 : 1 to 1 :4, in particular in the range from 1 : 1 to 1 :2, specifically from 1 : 1.1 to 1 : 1.4.
The ratio of imine of the formula (IV) to the azide of the formula (V) can vary. A significant excess is not critical for the reaction, but is uneconomic. Preferably, the ratio of imine of the formula (IV) to the azide of the formula (V) is in the range from 1 : 1 to 1 :3, in particular in the range from 1 : 1 to 1 :2, specifically in the range from 1 : 1.0 to 1 : 1.3. Since preferably the imines of the formula (IV) are not isolated, the required quantitative ratio is determined with regard to the amount of acid halide of the formula (II) used.
The present invention is illustrated in more detail by reference to the examples below, without thereby limiting the invention thereto. Preparation examples:
Example 1
At room temperature, 10 g of benzoyl chloride (71 mmol) were admixed with 3.7 g (92 mmol) of methyl isocyanide. The mixture was then heated at 60°C for 3 hours. The mixture was admixed with 25 ml of acetonitrile and cooled to 0°C. The reaction mixture was added to 4.6 g of sodium azide (71 mmol) in 9.1 g of 2,6-dimethylpyridine (85 mmol) in 25 ml of acetonitrile at 0°C. The mixture was then heated to 60°C and stirred at this temperature for 1 hour. At room temperature, 100 ml of water and 100 ml of ethyl acetate were added to the mixture. The organic phase was separated off and the aqueous phase was extracted with 100 ml of ethyl acetate. The combined organic phases were dried over magnesium sulphate and the solvent was removed in vacuo. This gave l-methyl-5-benzoyltetrazole in a yield of 82% (purity 90%o) based on the acid chloride used. The crude product could be recrystallized from 20 ml of isopropanol, giving 9.4 g of l-methyl-5-benzoyltetrazole (purity 97.4%).
'H-NMR (DMSO, 298K) δ: 4.39 (s, 3H), 7.65 (t, 2H), 7.80 (t, 1H), 8.27 (d, 2H)
Example 2
At room temperature, 10 g of benzoyl chloride (71 mmol) were admixed with 3.7 g (92 mmol) of methyl isocyanide. The mixture was then heated at 60°C for 2 hours. The mixture was admixed with 25 ml of acetonitrile and cooled to 0°C. This reaction mixture was added to 4.6 g of sodium azide (71 mmol) in 25 ml of acetonitrile at 0°C. The mixture was then heated to 60°C to 65°C and stirred at this temperature for 16 hours. At room temperature, 100 ml of water and 100 ml of ethyl acetate were added to the mixture. The organic phase was separated off and the aqueous phase was extracted with 100 ml of ethyl acetate. The combined organic phases were dried over magnesium sulphate and the solvent was removed in vacuo. The crude product could be recrystallized from 20 ml of isopropanol, giving 8.7 g of 1-methyl- 5-benzoyltetrazole (purity 99.4%>). This corresponds to a yield of 65%o, based on the acid chloride used. Example 3
At room temperature, 1 g of benzoyl chloride (7.1 mmol) was admixed with 0.38 g (9.2 mmol) of methyl isocyanide. The mixture was then heated at 60°C for 3 hours. The mixture was admixed with 2.5 ml of acetonitrile and cooled to 0°C. This reaction mixture was added to 0.46 g of sodium azide (7.1 mmol) in 0.6 g of pyridine (8.5 mmol) in 2.5 ml of acetonitrile at 0°C. The mixture was then heated to 60°C and stirred at this temperature for 1 hour. At room temperature, 10 ml of water and 10 ml of ethyl acetate were added to the mixture. The organic phase was separated off and the aqueous phase was extracted with 10 ml of ethyl acetate. The combined organic phases were dried over magnesium sulphate and the solvent was removed in vacuo. This gave l-methyl-5-benzoyltetrazole in a yield of 70.5% (purity 89%), based on the acid chloride used.
Example 4
At room temperature, 10 g of benzoyl chloride (71 mmol) were admixed with 3.7 g (92 mmol) of methyl isocyanide. The mixture was then heated at 60°C for 3 hours. The mixture was admixed with 25 ml of acetonitrile and cooled to 0°C. This reaction mixture was added to 4.6 g of sodium azide (71 mmol) in 1.1 g (14 mmol) of pyridine in 25 ml of acetonitrile at 0°C. The mixture was then heated to 60°C and stirred at this temperature for 1 hour. At room temperature, 100 ml of water and 100 ml of ethyl acetate were added to the mixture. The organic phase was separated off and the aqueous phase was extracted with 100 ml of ethyl acetate. The combined organic phases were dried over magnesium sulphate and the solvent was removed in vacuo. The crude product was recrystallized from 20 ml of isopropanol, giving

Claims

Patent claims
1. Process for the preparation of 5 -substituted 1-alkyltetrazoles of the formula (I)
o f
N -N
in which
R1 is alkyl, or phenyl optionally mono substituted by halogen, cyano, nitro, Ci-Cg-alkyl, Q-
Cg-alkoxy, methylsulphonyl, trifluoromethyl or aryl,
R is Ci-Ci2-alkyl, Ci-Ci2-haloalkyl or an alkoxyalkyl of the formula -[A-0]m-B,
A is C2-C i-alkanediyl (alkylene),
B is Ci-Ce-alkyl,
m is 1 or 2, characterized in that
(1) in a first step, an acid chloride of the formula (II)
O
R1Xx (ID in which R1 has the meanings given above and X is halogen,
is reacted with an alkyl isocyanide of the formula (III)
R— NC (III)
in which R2 has the meanings given above, and the imines of the formula (IV) obtained in this way
Figure imgf000009_0001
in which R1, R2 and X have the meanings given above,
(2) are reacted in a second step with azides of the formula (V)
R— 3
in which
R3 is sodium, potassium, tetrabutylammonium, trimethylsilyl, diphenylphosphoryl, optionally in the presence of a base.
Process according to Claim 1, characterized in that acid chlorides of the formula (II) and alkyl isocyanides of the formula (III) are used in which R1 is Ci-Cg-alkyl, or phenyl optionally mono substituted by fluorine, chlorine, bromine, iodine, cyano, nitro, Ci-C6-alkyl, methylsulphonyl, trifluoromethyl or phenyl or naphthyl, X is fluorine, chlorine or bromine,
R is Ci-C8-alkyl, Ci-C8-haloalkyl or an alkoxyalkyl of the formula -[A-0]m-B,
A is -(CH2)2-, -(CH2)3-, -CH(CH3)- or -CH(CH3)CH2-,
B is Ci-Ce-alkyl,
m is 1.
3. Process according to Claim 1, characterized in that acid chlorides of the formula (II) and alkyl isocyanides of the formula (III) are used in which R1 is Ci-C6-alkyl, or phenyl optionally monosubstituted by fluorine, chlorine, Ci-C i-alkyl or
Ci-C3-alkoxy,
X is fluorine or chlorine,
R is Ci-C4-alkyl, Ci-C4-haloalkyl or an alkoxyalkyl of the formula -[A-0]m-B,
A is -(CH2)2- or -CH(CH3)CH2-,
B is Ci-C4-alkyl,
m is 1.
4. Process according to Claim 1, characterized in that acid chlorides of the formula (II) and alkyl isocyanides of the formula (III) are used in which
R1 is an unsubstituted phenyl,
X is chlorine,
R2 is methyl.
5. Process according to one of Claims 1 to 4, characterized in that step (2) is carried out in the presence of a base.
6. Process according to one of Claims 1 to 5, characterized in that the imines of the formula (IV) are not isolated and are further used in situ.
PCT/EP2011/053660 2010-03-12 2011-03-11 Process for the preparation of 5-substituted 1-alkyltetrazoles WO2011110651A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
CN201180013193.9A CN102906075B (en) 2010-03-12 2011-03-11 The preparation method of the 1-alkyl tetrazolium that 5-replaces
ES11709678.4T ES2450124T3 (en) 2010-03-12 2011-03-11 Procedure for the preparation of 5-substituted alkyltetrazoles
BR112012022882A BR112012022882A2 (en) 2010-03-12 2011-03-11 process for preparing 5-substituted 1-alkyl tetrazoles
KR1020127024560A KR20130016233A (en) 2010-03-12 2011-03-11 Process for the preparation of 5-substituted 1-alkyltetrazoles
EP11709678.4A EP2545040B1 (en) 2010-03-12 2011-03-11 Process for the preparation of 5-substituted 1-alkyltetrazoles
US13/582,026 US8536211B2 (en) 2010-03-12 2011-03-11 Process for the preparation of 5-substituted 1-alkyltetrazoles
MX2012010443A MX2012010443A (en) 2010-03-12 2011-03-11 Process for the preparation of 5-substituted 1-alkyltetrazoles.
JP2012556528A JP5792205B2 (en) 2010-03-12 2011-03-11 Process for preparing 5-substituted 1-alkyltetrazoles
DK11709678.4T DK2545040T3 (en) 2010-03-12 2011-03-11 PROCEDURE FOR THE PREPARATION OF 5-SUBSTITUTED 1-ALKYLTETRAZOLES
IL221184A IL221184A (en) 2010-03-12 2012-07-30 Process for the preparation of 5-substituted 1-alkyltetrazoles

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP10156377 2010-03-12
EP10156377.3 2010-03-12
US31385910P 2010-03-15 2010-03-15
US61/313,859 2010-03-15

Publications (1)

Publication Number Publication Date
WO2011110651A1 true WO2011110651A1 (en) 2011-09-15

Family

ID=42111752

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/053660 WO2011110651A1 (en) 2010-03-12 2011-03-11 Process for the preparation of 5-substituted 1-alkyltetrazoles

Country Status (12)

Country Link
US (1) US8536211B2 (en)
EP (1) EP2545040B1 (en)
JP (1) JP5792205B2 (en)
KR (1) KR20130016233A (en)
CN (1) CN102906075B (en)
BR (1) BR112012022882A2 (en)
DK (1) DK2545040T3 (en)
ES (1) ES2450124T3 (en)
IL (1) IL221184A (en)
MX (1) MX2012010443A (en)
TW (1) TWI477491B (en)
WO (1) WO2011110651A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013117582A1 (en) 2012-02-09 2013-08-15 Bayer Intellectual Property Gmbh Process for the preparation of n-hydroxy-1-(1-alkyl-1h-tetrazol-5-yl)-1-phenylmethanimine derivatives
WO2013187325A1 (en) 2012-06-12 2013-12-19 日本曹達株式会社 Method for producing azide compound, and method for producing 1h-tetrazole derivative
WO2013187327A1 (en) 2012-06-12 2013-12-19 日本曹達株式会社 Method for producing 1h-tetrazole derivative
WO2016142364A1 (en) 2015-03-10 2016-09-15 Lonza Ltd Method for preparation of certain 1,5 disubstituted tetrazoles
EP3112344A1 (en) 2015-06-30 2017-01-04 Lonza Ltd Method for preparation of certain thioacetamides

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010000841A1 (en) 2008-07-04 2010-01-07 Bayer Cropscience Sa Fungicide hydroximoyl-tetrazole derivatives

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3753759B2 (en) * 1995-06-09 2006-03-08 東洋化成工業株式会社 Process for producing 5-aminotetrazole
CN1212963A (en) * 1998-09-26 1999-04-07 杭州民生凯普医药化工有限公司 Method for preparing disodium salt of 5-mercapto-1H-tetrazole-1-methyl-sulfonic acid
JP2000281662A (en) * 1999-03-31 2000-10-10 Masuda Kagaku Kogyo Kk Production of tetrazoles
JP2004131392A (en) * 2002-10-08 2004-04-30 Sumitomo Chem Co Ltd Tetrazole compound and application thereof
KR100780906B1 (en) * 2003-10-10 2007-11-30 도요 가세이 고교 가부시키가이샤 Process for production of 1-aryl-5-trifluoromethyl-1h-tetrazoles
CN1261417C (en) * 2004-03-24 2006-06-28 南通市华峰化工有限责任公司 Method for producing sulf-5 position substituted tetrazole
CN1562981A (en) * 2004-03-24 2005-01-12 南通市华峰化工有限责任公司 Method for fabricating halogenation linear chain paraffin tetrazole
CN1235886C (en) * 2004-03-24 2006-01-11 南通市华峰化工有限责任公司 Method for preparing sulfhydyl-(m-benzamido) phenyl tetrazole
CN100534987C (en) * 2005-04-22 2009-09-02 横店集团成都分子实验室有限公司 New method for preparing 2-methoxy-5(5-trifluoromethyl-1H-tetraazo-1-group) benzaldehyde
CN100462360C (en) * 2005-08-15 2009-02-18 上海立科药物化学有限公司 N-cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole synthesis method
CN100344617C (en) * 2005-11-30 2007-10-24 浙江工业大学 Chemical synthesizing method of tetrazole compound
MX2010013903A (en) * 2008-07-04 2011-02-15 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives.
CN102341378B (en) * 2009-03-11 2015-09-09 日本曹达株式会社 The preparation method of 1-alkyl-5-benzoyl-1H-TETRAZOLE derivative

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010000841A1 (en) 2008-07-04 2010-01-07 Bayer Cropscience Sa Fungicide hydroximoyl-tetrazole derivatives

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANGEW. CHEM. INT. ED., vol. 4, 1965, pages 472 - 484
CAN. J CHEM., vol. 49, 1971, pages 2139 - 2142
CHEM. BER., vol. 94, 1961, pages 1116 - 1121
IVAR UGI, UWE FETZER: "Die Addition von Carbonsäurenitrilen an Isonitrile", CHEM. BER., vol. 94, no. 4, 1 April 1961 (1961-04-01), pages 1116 - 1121, XP002580502 *
J AMER. CHEM. SOC., vol. 85, 1963, pages 2967 - 2976
PETER YATES, DONALS FARNUM: "Aliphatic Diazo Compounds", J. AMER. CHEM. SOC., vol. 85, no. 19, 1 October 1963 (1963-10-01), pages 2967 - 2976, XP002580503 *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9212152B2 (en) 2012-02-09 2015-12-15 Bayer Intellectual Property Gmbh Process for the preparation of N-hydroxy-1-(1-alkyl-1H-tetrazol-5-yl)-1-phenylmethanimine derivatives
JP2015508067A (en) * 2012-02-09 2015-03-16 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー Process for preparing N-hydroxy-1- (1-alkyl-1H-tetrazol-5-yl) -1-phenylmethanimine derivatives
WO2013117582A1 (en) 2012-02-09 2013-08-15 Bayer Intellectual Property Gmbh Process for the preparation of n-hydroxy-1-(1-alkyl-1h-tetrazol-5-yl)-1-phenylmethanimine derivatives
CN104080776A (en) * 2012-02-09 2014-10-01 拜耳知识产权有限责任公司 Process for the preparation of N-hydroxy-1-(1-alkyl-1H-tetrazol-5-yl)-1-phenylmethanimine derivatives
KR20150006878A (en) 2012-06-12 2015-01-19 닛뽕소다 가부시키가이샤 Method for producing 1ｈ-tetrazole derivative
KR20150008896A (en) 2012-06-12 2015-01-23 닛뽕소다 가부시키가이샤 Method for producing azide compound, and method for producing 1h-tetrazole derivative
WO2013187325A1 (en) 2012-06-12 2013-12-19 日本曹達株式会社 Method for producing azide compound, and method for producing 1h-tetrazole derivative
CN104350043A (en) * 2012-06-12 2015-02-11 日本曹达株式会社 Method for producing 1h-tetrazole derivative
CN104350038A (en) * 2012-06-12 2015-02-11 日本曹达株式会社 Method for producing azide compound, and method for producing 1H-tetrazole derivative
WO2013187327A1 (en) 2012-06-12 2013-12-19 日本曹達株式会社 Method for producing 1h-tetrazole derivative
KR101639507B1 (en) 2012-06-12 2016-07-13 닛뽕소다 가부시키가이샤 1- method for producing 1-tetrazole derivative
US9630933B2 (en) 2012-06-12 2017-04-25 Nippon Soda Co., Ltd. Method for producing 1-H-tetrazole derivative
CN104350038B (en) * 2012-06-12 2017-05-24 日本曹达株式会社 Method for producing azide compound, and method for producing 1H-tetrazole derivative
WO2016142364A1 (en) 2015-03-10 2016-09-15 Lonza Ltd Method for preparation of certain 1,5 disubstituted tetrazoles
EP3112344A1 (en) 2015-06-30 2017-01-04 Lonza Ltd Method for preparation of certain thioacetamides

Also Published As

Publication number Publication date
TWI477491B (en) 2015-03-21
MX2012010443A (en) 2012-12-05
BR112012022882A2 (en) 2015-09-29
CN102906075A (en) 2013-01-30
JP5792205B2 (en) 2015-10-07
KR20130016233A (en) 2013-02-14
TW201139389A (en) 2011-11-16
EP2545040B1 (en) 2013-12-11
DK2545040T3 (en) 2014-03-10
ES2450124T3 (en) 2014-03-24
CN102906075B (en) 2016-01-13
US20120330027A1 (en) 2012-12-27
JP2013522176A (en) 2013-06-13
IL221184A (en) 2015-08-31
EP2545040A1 (en) 2013-01-16
US8536211B2 (en) 2013-09-17

Similar Documents

Publication Publication Date Title
EP2545040B1 (en) Process for the preparation of 5-substituted 1-alkyltetrazoles
US10981940B2 (en) Trityl protecting agent
US8680283B2 (en) Process for the preparation of 5-substituted 1-alkyltetrazolyl oxime derivatives
CA2972161A1 (en) Method for preparation of certain 1,5 disubstituted tetrazoles
US9212152B2 (en) Process for the preparation of N-hydroxy-1-(1-alkyl-1H-tetrazol-5-yl)-1-phenylmethanimine derivatives
EP2585449B1 (en) Process for the preparation of 5-substituted 1-alkyltetrazolyl oxime derivatives
KR101069222B1 (en) Method for producing 3,4-dichloro-N-2-cyano-phenyl-5-isothiazole carboxamide
JP2007223957A (en) Method for producing benzoic acid ester
JP2000504675A (en) Method for producing substituted cyanophenyluracil from substituted aminoalkenoic cyanophenylamides
WO2010047400A1 (en) Method for producing oxadiazolinone compound and intermediate thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180013193.9

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11709678

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 221184

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2011709678

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 13582026

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: MX/A/2012/010443

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2012556528

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 7963/DELNP/2012

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 20127024560

Country of ref document: KR

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112012022882

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112012022882

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20120911